Xeptiva Therapeutics

  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • News
    • See news
    • Press releases
  • Blog
  • Contact
  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • News
    • See news
    • Press releases
  • Blog
  • Contact

PRESS

Press releases

Josefina Correa (CEO) and Emiliano Trias (CSO) discussed about the biotech ecosystem in Uruguay and Xeptiva's future plans for technology.
Josefina Correa (CEO) and Emiliano Trias (CSO) discussed about the biotech ecosystem in Uruguay and Xeptiva's technology
Veterinary School in Uruguay is looking for dogs with chronic pain for an experimental vaccine study.
Veterinary School in Uruguay is looking for dogs with chronic pain for an experimental vaccine study.
Uruguayan scientists develop vaccine for chronic pain
Vaccines to alleviate chronic pain in pets
The Institut Pasteur and the start-up Xeptiva Therapeutics have developed a vaccine to treat pain in pets
Sergio Fogel will invest millions in a company run by two young Uruguayans
Entrepreneurships with sustainable DNA, four young people who opted for triple impact
Time to become an investment magnet
A Uruguayan start-up advances in therapy to block pain in dogs, cats and horses

COMPANY

About Us
Team

INNOVATION

Technology
Pipeline
Target diseases

NEWS

See News
Press releases

cONTACT

BLOG

© COPYRIGHT 2023. ALL RIGHTS RESERVED.